BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

513 related articles for article (PubMed ID: 25891086)

  • 1. Green tea polyphenol epigallocatechin-3-gallate ameliorates insulin resistance in non-alcoholic fatty liver disease mice.
    Gan L; Meng ZJ; Xiong RB; Guo JQ; Lu XC; Zheng ZW; Deng YP; Luo BD; Zou F; Li H
    Acta Pharmacol Sin; 2015 May; 36(5):597-605. PubMed ID: 25891086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decaffeinated green tea extract rich in epigallocatechin-3-gallate prevents fatty liver disease by increased activities of mitochondrial respiratory chain complexes in diet-induced obesity mice.
    Santamarina AB; Carvalho-Silva M; Gomes LM; Okuda MH; Santana AA; Streck EL; Seelaender M; do Nascimento CM; Ribeiro EB; Lira FS; Oyama LM
    J Nutr Biochem; 2015 Nov; 26(11):1348-56. PubMed ID: 26300331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigallocatechin gallate attenuated non-alcoholic steatohepatitis induced by methionine- and choline-deficient diet.
    Ding Y; Sun X; Chen Y; Deng Y; Qian K
    Eur J Pharmacol; 2015 Aug; 761():405-12. PubMed ID: 25967348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Green tea polyphenol epigallocatechin-3-gallate alleviates nonalcoholic fatty liver disease and ameliorates intestinal immunity in mice fed a high-fat diet.
    Huang J; Li W; Liao W; Hao Q; Tang D; Wang D; Wang Y; Ge G
    Food Funct; 2020 Nov; 11(11):9924-9935. PubMed ID: 33095225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ameliorative effects of lutein on non-alcoholic fatty liver disease in rats.
    Qiu X; Gao DH; Xiang X; Xiong YF; Zhu TS; Liu LG; Sun XF; Hao LP
    World J Gastroenterol; 2015 Jul; 21(26):8061-72. PubMed ID: 26185377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigallocatechin-3-Gallate Dampens Non-Alcoholic Fatty Liver by Modulating Liver Function, Lipid Profile and Macrophage Polarization.
    Du Y; Paglicawan L; Soomro S; Abunofal O; Baig S; Vanarsa K; Hicks J; Mohan C
    Nutrients; 2021 Feb; 13(2):. PubMed ID: 33670347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigallocatechin-3-gallate ameliorates glucolipid metabolism and oxidative stress in type 2 diabetic rats.
    Li W; Zhu C; Liu T; Zhang W; Liu X; Li P; Zhu T
    Diab Vasc Dis Res; 2020; 17(6):1479164120966998. PubMed ID: 33280417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leonurus japonicus Houtt Attenuates Nonalcoholic Fatty Liver Disease in Free Fatty Acid-Induced HepG2 Cells and Mice Fed a High-Fat Diet.
    Lee MR; Park KI; Ma JY
    Nutrients; 2017 Dec; 10(1):. PubMed ID: 29295591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pu-erh tea extract ameliorates high-fat diet-induced nonalcoholic steatohepatitis and insulin resistance by modulating hepatic IL-6/STAT3 signaling in mice.
    Cai X; Fang C; Hayashi S; Hao S; Zhao M; Tsutsui H; Nishiguchi S; Sheng J
    J Gastroenterol; 2016 Aug; 51(8):819-29. PubMed ID: 26794005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigallocatechin-3-Gallate-Rich Green Tea Extract Ameliorates Fatty Liver and Weight Gain in Mice Fed a High Fat Diet by Activating the Sirtuin 1 and AMP Activating Protein Kinase Pathway.
    Bae UJ; Park J; Park IW; Chae BM; Oh MR; Jung SJ; Ryu GS; Chae SW; Park BH
    Am J Chin Med; 2018; 46(3):617-632. PubMed ID: 29595075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Green tea, black tea, and epigallocatechin modify body composition, improve glucose tolerance, and differentially alter metabolic gene expression in rats fed a high-fat diet.
    Chen N; Bezzina R; Hinch E; Lewandowski PA; Cameron-Smith D; Mathai ML; Jois M; Sinclair AJ; Begg DP; Wark JD; Weisinger HS; Weisinger RS
    Nutr Res; 2009 Nov; 29(11):784-93. PubMed ID: 19932867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Red pitaya betacyanins protects from diet-induced obesity, liver steatosis and insulin resistance in association with modulation of gut microbiota in mice.
    Song H; Chu Q; Yan F; Yang Y; Han W; Zheng X
    J Gastroenterol Hepatol; 2016 Aug; 31(8):1462-9. PubMed ID: 26699443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Green Tea Polyphenol EGCG Alleviates Metabolic Abnormality and Fatty Liver by Decreasing Bile Acid and Lipid Absorption in Mice.
    Huang J; Feng S; Liu A; Dai Z; Wang H; Reuhl K; Lu W; Yang CS
    Mol Nutr Food Res; 2018 Feb; 62(4):. PubMed ID: 29278293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coadministration of epigallocatechin-3-gallate (EGCG) and caffeine in low dose ameliorates obesity and nonalcoholic fatty liver disease in obese rats.
    Yang Z; Zhu MZ; Zhang YB; Wen BB; An HM; Ou XC; Xiong YF; Lin HY; Liu ZH; Huang JA
    Phytother Res; 2019 Apr; 33(4):1019-1026. PubMed ID: 30746789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decaffeinated green tea extract rich in epigallocatechin-3-gallate improves insulin resistance and metabolic profiles in normolipidic diet--but not high-fat diet-fed mice.
    Santana A; Santamarina A; Souza G; Mennitti L; Okuda M; Venancio D; Seelaender M; do Nascimento CO; Ribeiro E; Lira F; Oyama L
    J Nutr Biochem; 2015 Sep; 26(9):893-902. PubMed ID: 26048201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigallocatechin Gallate Suppresses Inflammatory Responses by Inhibiting Toll-like Receptor 4 Signaling and Alleviates Insulin Resistance in the Livers of High-fat-diet Rats.
    Hou H; Yang W; Bao S; Cao Y
    J Oleo Sci; 2020 May; 69(5):479-486. PubMed ID: 32281563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic effects of globular adiponectin in diabetic rats with nonalcoholic fatty liver disease.
    Ma H; Cui F; Dong JJ; You GP; Yang XJ; Lu HD; Huang YL
    World J Gastroenterol; 2014 Oct; 20(40):14950-7. PubMed ID: 25356056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary (-)-Epigallocatechin-3-gallate Supplementation Counteracts Aging-Associated Skeletal Muscle Insulin Resistance and Fatty Liver in Senescence-Accelerated Mouse.
    Liu HW; Chan YC; Wang MF; Wei CC; Chang SJ
    J Agric Food Chem; 2015 Sep; 63(38):8407-17. PubMed ID: 26152236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ugonin J improves metabolic disorder and ameliorates nonalcoholic fatty liver disease by regulating the AMPK/AKT signaling pathway.
    Chang TC; Chiou WC; Lai WH; Huang HC; Huang YL; Liu HK; Liang YC; Huang C
    Pharmacol Res; 2021 Jan; 163():105298. PubMed ID: 33220422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Glucagon-Like Peptide-1 Analogue Liraglutide Inhibits Oxidative Stress and Inflammatory Response in the Liver of Rats with Diet-Induced Non-alcoholic Fatty Liver Disease.
    Gao H; Zeng Z; Zhang H; Zhou X; Guan L; Deng W; Xu L
    Biol Pharm Bull; 2015; 38(5):694-702. PubMed ID: 25947915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.